Menu
Search
|

Menu

Close
X

Genomma Lab Internacional SAB de CV LABB.MX (Mexico Stock Exchange)

19.41 MXN
-0.08 (-0.41%)
As of 11:06 AM EST
chart
Previous Close 19.49
Open 19.51
Volume 386,734
3m Avg Volume 4,116,159
Today’s High 19.55
Today’s Low 19.25
52 Week High 25.08
52 Week Low 18.85
Shares Outstanding (mil) 1,048.73
Market Capitalization (mil) 20,439.81
Forward P/E 14.97
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.85 Mean rating from 13 analysts

KEY STATS

Revenue (mm, MXN)
FY17
12,078
FY16
11,316
FY15
11,042
EPS (MXN)
FY17
1.302
FY16
-1.603
FY15
-1.084
*Note: Units in Millions of Mexican Pesos
**Note: Units in Mexican Pesos

KEY RATIOS

Price to Earnings (TTM)
vs sector
14.97
34.59
Price to Sales (TTM)
vs sector
1.69
8.08
Price to Book (MRQ)
vs sector
2.98
5.24
Price to Cash Flow (TTM)
vs sector
13.85
25.98
Total Debt to Equity (MRQ)
vs sector
25.20
15.60
LT Debt to Equity (MRQ)
vs sector
25.20
12.18
Return on Investment (TTM)
vs sector
14.22
13.67
Return on Equity (TTM)
vs sector
19.05
15.40

EXECUTIVE LEADERSHIP

Rodrigo Alonso Herrera Aspra
Chairman of the Board, Independent Director, Since 2016
Salary: --
Bonus: --
Maximo Juda
Chief Executive Officer, Since 2015
Salary: --
Bonus: --
Antonio Zamora Galland
Executive Vice President, Chief Financial Officer, Since 2015
Salary: --
Bonus: --
Marco Sparvieri
Executive Vice-President of Global Sales, Since 2015
Salary: --
Bonus: --
Alejandro Baston Patino
Vice-President of International and Sales Development, Since 2015
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Pharmaceuticals
Address:

Edificio Samara
Antonio Dovali Jaime no. 70 Piso
Colonia Santa Fe
MEXICO, D.F.     01210

Phone: +5255.50810000

Genomma Lab Internacional SAB de CV is a Mexico-based over-the-counter pharmaceutical (OTC pharmaceutical), generic drugs (GD) and personal care products company. The Company is engaged in the development, distribution and marketing of a range of products within different brands, for such treatments as anti-acne, varicose vein, hair loss, sexual stimulation and influenza; as well as analgesics and antifungals. The Company’s product portfolio includes such brands as Asepxia, Cicatricure, Goicoechea, Bengue, Diabet TX, Genoprazol, Goicotabs, Shot B, SilkaMedic, Siluet 40, Nikzon, X Ray, Next, Touch Me, Lomecan V and QG5, among others. The Company is a parent of a number of controlled entities, which have operations established in Mexico, the United States, Peru, Chile, Ecuador and Honduras, among others. In June 2014, the Company acquired 50% stake in Grupo Comercial e Industrial Marzam SA de CV.

SPONSORED STORIES